- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06065384
Neural Plasticity and Motor Recovery After Early and Intensive Upper Extremity Motor Training in People With c-SCI (REPAIR-SCI)
Neural Plasticity and Motor Recovery After Early and Intensive Upper Extremity Motor Training in People With Cervical Spinal Cord Injury
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background of the study:
Paralysis or paralysis is the most common effect of spinal cord injury (SCI) on individuals. Paralysis affects the ability to walk, perform self-care, live independently and participate in work and leisure activities. In individuals with cervical spinal cord injury, arm and hand function is very important. The most promising and easily implemented intervention that could promote neurological recovery and make a lasting difference in the lives of people with spinal cord injury is early and intensive motor training aimed at recovery below the injury level. This intervention takes advantage of the early plasticity of the nervous system. By maximizing muscle activation in the first few days after injury, we can target the nervous system's unique capacity for neural plasticity where changes can occur in central and peripheral motor systems.
Objective of the study:
This project aims to investigate peripheral and central neuroplasticity following an early (<10 weeks after injury) and intensive (10weeks of 12 hours of additional therapy) upper extremity motor training program (EIUMT) aimed at recovery below the lesion level.This project has 4 objectives: to investigate 1) central neural plasticity (identify changes in cortical neuroplasticity and corticospinal excitability; 2) peripheral neural plasticity (identify change in axonal excitability and number of motor units); 3) clinical motor recovery of the upper limbs and 4) relationships between dose dimensions of motor intervention and clinical and neurophysiological outcome measures after EIUMT. Advanced neurophysiological measurements and clinical measurements will be taken before and after EIUMT and at 6-month follow-up.
Study design:
a multicenter pragmatic randomised controlled study in 2 countries
Study population:
40 persons with cervical spinal cord injury (20 participants in the control and intervention groups) Inclusion criteria: Individuals are eligible to participate if they have suffered a traumatic or non-traumatic cervical spinal cord injury(with neurological level C4 or below) within the previous 10 weeks, have AIS (ASIA Impairment Scale) A lesion with motor function more than three levels below motor level (on one or both sides) or have AIS C or AIS D lesion (as defined by the International Standards for the Neurological Classification of spinal cord injury), are older than 16 years of age, have received permission to begin rehabilitation and are likely to remain an inpatient for the next 10 weeks.
Exclusion criteria: Participants will be excluded if they have a significant medical or physical condition or psychiatric illness that could prevent the person from participating in the study, or would place the person at unacceptable risk if they were to participate.
Intervention:
The intervention group receives 12 hours of motor training each week. This involves active and targeted motor training of all affected muscles below the injury level in the context of functional activities.
The control group receives only standard rehabilitation and care.
Primary study parameters/outcome of the study:
Central plasticity via: Single pulse TMS (transcranial magnetic stimulation) (cortical mapping and rest motor threshold) 10 weeks after randomisation
Secundary study parameters/outcome of the study:
Clinical Measures: Upper Extremity Motor Score, Spinal Cord Independence Measure (SClM-zelfzorg); Van Lieshout Test (VLT);Grades redefined assessment of strength sensibility and Prehension (GRASSP); Hand-Held Dynamometry; accelerometry (session density: active therapy time/session length); perceived difficulty and exertion) Central plasticity: Paired pulse TMS: (SICI (short interval intracortical inhibition); LICI (long interval intracortical inhibition); SICF (short interval intracortical inhibition); peripheral plasticity: NET (Nerve excitability testing) en MScanFit MUNE(Compound muscle action potential (CMAP).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Annemie Spooren, Prof. Dr.
- Phone Number: 11269332
- Email: annemie.spooren@uhasselt.be
Study Contact Backup
- Name: Lisa Tedesco Triccas, Prof. Dr.
- Email: lisa.tedescotriccas@uhasselt.be
Study Locations
-
-
-
Gent, Belgium
- UZGent
-
Contact:
- Kristine Oostra, Prof. Dr.
-
Leuven, Belgium
- UZLeuven Campus Pellenberg
-
Contact:
- Koen Peers, Prof. Dr.
-
-
-
-
-
Hoensbroek, Netherlands
- Zorggroep Adelante
-
Contact:
- Charlotte Van Laake, dr.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Traumatic or non-traumatic C-SCI below C4 in the preceding 10 weeks; age over 16 years; have an incomplete SCI or an AIS A SCI with zones of partial motor paralysis (as defined by the International Standards for the Neurological Classification of SCI (ISNCI) and medically stable.
Exclusion Criteria:
- SCI with ASIA Impairment Scale (AIS) A without zones of partial preservation (decided based on former studies [58]) and expertise of the team; SCI with any significant medical condition that could prevent the person from participating. In order to ensure TMS measurement can be performed, patients will only be included for this measure if they have a positive response to motor evoked potential measurement (MEP+) [59] and will be excluded in the presence of contraindications for TMS application such as epilepsy, metal implants in the brain,defibrillator, pacemaker and pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: intensive upper limb training
The intervention group receives 12 hours of motor training each week upon usual care during 10 weeks.
This involves active and targeted motor training of all affected muscles below the injury level in the context of functional activities.
|
Intervention group: receive an extra 12 hours of motor training each week (distributed over the week) for 10 weeks.
It will involve active and targeted motor training of all affected muscles of the upper limb below the level of the injury within the context of practice of functional activities.
Interventions will be goal directed and individualized to the needs of each participant with a focus on training that addresses each person's specific motor problem, promoting motor learning as well as stimulating neural plasticity.
All patients will continue to receive usual physiotherapy and usual rehabilitation.
|
Other: usual care
The control group receives only standard rehabilitation and care
|
usual rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
changes in single pulse TMS: mapping
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
to evaluate changes in cortical reorganisation
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
changes in single pulse TMS: resting motor threshold
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
to asses changes in cortical reactivity
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
changes SICI
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
to evaluatie changes in Short interval intracortical inhibition
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
changes SICF
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
short-interval intracortical facilitation
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
changes in LICI
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
long-interval intracortical inhibition
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
changes in MscanFit MUNE
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
Compound muscle action potential (CMAP) scans will be recorded
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
changes in NET (Nerve excitability testing)
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
Strength duration time constant (SDTC), threshold electrotonus (TE), I/V relationship (I/V) and recovery cycles (RC) will be measured.
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
changes in behavioral measures: Upper extremity motor score
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
score on 50
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
changes in Spinal Cord independence Measures
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
questionaire: self-care score
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
changes in Van Lieshout Test
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
basis upper extremity skills
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
changes in GRASSP
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
Grades redefined assessment of strength sensibility and Prehension
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
changes in hand held dynamometry
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
strength in hand
|
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
therapy difficulty
Time Frame: before session; after completion of session an average of 60 minutes
|
VAS
|
before session; after completion of session an average of 60 minutes
|
session density
Time Frame: start intervention up to 10 weeks
|
accelerometry
|
start intervention up to 10 weeks
|
therapy perceived exertion
Time Frame: before session; after completion of session an average of 60 minutes
|
VAS
|
before session; after completion of session an average of 60 minutes
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Annemie Spooren, Prof. Dr., Hasselt University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REPAIR-SCI_UH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
pseudomised data will be shared with the Aarhys university because they will assist in data-analyses.
the protocol will be shared with the partners (Aarhus University, Sydney University, UZGent, UZLeuven and Adelante Zorggroep)
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Shepherd Center, Atlanta GACompletedInjuries, Spinal Cord
-
Wroclaw Medical UniversityInstitute of Immunology and Experimental Therapy of the Polish Academy of... and other collaboratorsUnknownComplete Spinal Cord InjuriesPoland
-
Lineage Cell Therapeutics, Inc.CompletedCervical Spinal Cord Injury | Spine Injury | Spinal Cord TraumaUnited States
Clinical Trials on experimental group: intensive motor training
-
Riphah International UniversityCompleted
-
MedStar National Rehabilitation NetworkGeorgetown University; University of Wisconsin, Madison; Medstar Health Research... and other collaboratorsUnknownStroke | Cerebrovascular Disorders | Brain Ischemia | Cerebral Infarction | Brain InfarctionUnited States
-
Riphah International UniversityRecruiting
-
University of KentuckyTerminatedStroke | HemiparesisUnited States
-
Kook-Hwan OhBaxter Healthcare CorporationCompletedRisk ReductionKorea, Republic of
-
Sara Shahid SallesWings for LifeTerminatedSpinal Cord Injuries | Tetraplegia, Unspecified, Incomplete, ChronicUnited States
-
University of KentuckyTerminatedStrokeUnited States
-
Universidad Autonoma de MadridUnknown
-
Riphah International UniversityCompletedStroke, CardiovascularPakistan
-
Dr. Sobia HasanRecruiting